Skip to main navigation
Centessa Pharmaceuticals
  • About Us
  • Team
  • Programs and Pipeline
    • Summary and Pipeline
    • Orexin Receptor 2 Agonist Program
    • LockBody® Technology Platform
  • Patients
  • Investors
  • News
  • Careers
  • About Us
  • Team
  • Programs and Pipeline
    • Summary and Pipeline
    • Orexin Receptor 2 Agonist Program
    • LockBody® Technology Platform
  • Patients
  • Investors
  • News
  • Careers
Centessa Pharmaceuticals
  • About Us
  • Team
  • Programs and Pipeline
    • Summary and Pipeline
    • Orexin Receptor 2 Agonist Program
    • LockBody® Technology Platform
  • Patients
  • Investors
  • News
  • Careers
Centessa Pharmaceuticals
  • About Us
  • Team
  • Programs and Pipeline
    • Summary and Pipeline
    • Orexin Receptor 2 Agonist Program
    • LockBody® Technology Platform
  • Patients
  • Investors
  • News
  • Careers
  • About Us
  • Team
  • Programs and Pipeline
    • Summary and Pipeline
    • Orexin Receptor 2 Agonist Program
    • LockBody® Technology Platform
  • Patients
  • Investors
  • News
  • Careers
Centessa Pharmaceuticals
  • About Us
  • Team
  • Programs and Pipeline
    • Summary and Pipeline
    • Orexin Receptor 2 Agonist Program
    • LockBody® Technology Platform
  • Patients
  • Investors
  • News
  • Careers
  • Overview
  • Press Releases
  • Events & Presentations
  • Financials
    SEC Filings Annual Reports
  • Stock Info
    Stock Quote & Chart Historical Price Lookup Analyst Coverage
  • Governance
    Documents & Charters Management Team Board of Directors Committee Composition
  • Annual General Meeting
  • Shareholder Resources
    FAQs Email Alerts Contact Us RSS Feeds PFIC Information

Annual General Meeting

2026

2025 Annual Report on Form 10-K
Notice of Annual General Meeting and Proxy Statement
UK Notice of Annual General Meeting
Form of Proxy

2025

2024 Annual Report on Form 10-K
Notice of Annual General Meeting and Proxy Statement
UK Notice of Annual General Meeting
Form of Proxy
2024 UK Annual Report and Accounts

2024

2023 Annual Report on Form 10-K
Notice of Annual General Meeting and Proxy Statement
UK Notice of Annual General Meeting
Form of Proxy
2023 UK Annual Report and Accounts

2023

2022 Annual Report on Form 10-K
Notice of Annual General Meeting and Proxy Statement
UK Notice of Annual General Meeting
Form of Proxy
2022 UK Annual Report and Accounts

2022

Notice of Annual General Meeting and Proxy Statement
2021 Annual Report on Form 10-K
Form of Proxy
2021 UK Annual Report and Accounts
Print Page
FAQs
Email Alerts
Contact Us
RSS Feeds

Centessa Pharmaceuticals
  • About Us
  • Team
  • Programs and Pipeline
  • Investors
  • News
  • Careers
Menu
  • About Us
  • Team
  • Programs and Pipeline
  • Investors
  • News
  • Careers
  • Privacy Notices
  • PFIC Information
Contact Us
Follow Us